Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2Phase 3 1

Status

Recruiting 3Active not recruiting 2

Sponsor Class

OTHER 4NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

CNS 14Genitourinary 10Sarcoma 9Head & Neck 6Thoracic 5Other solid neoplasm 5Gastrointestinal 5Tumor-Agnostic 3Breast 3Endocrine 2Plasma cell 1Lymphoid 1

Conditions

Esophageal Neoplasms 3Pancreatic Neoplasms 1Clinical Stage I Esophageal Adenocarcinoma AJCC v8 1Carcinoma, Squamous Cell 1Adenocarcinoma 1

Interventions

Oxaliplatin 297Fluorouracil 272Bevacizumab 235Gemcitabine 234Leucovorin 212Capecitabine 204pembrolizumab 200Nivolumab 157Irinotecan 156Cisplatin 148Specimen Handling 143Magnetic Resonance Spectroscopy 130130-nm albumin-bound paclitaxel 115Paclitaxel 109durvalumab 104Cetuximab 102Radiotherapy 96atezolizumab 92Biopsy 92Drug Therapy 91Albumin-Bound Paclitaxel 78tislelizumab 77Taxes 73Folfox protocol 68lenvatinib 67Carboplatin 65regorafenib 60Blood Specimen Collection 60trifluridine tipiracil drug combination 52Ipilimumab 52

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Proton Therapy × Gastrointestinal × 1 year × Clear all
NCT01684904 2026-06-05

Proton Therapy for Esophageal Cancer

Loma Linda University

Phase NA Recruiting
38 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT03801876 2026-05-07

Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer

NRG Oncology

Phase 3 Recruiting
300 enrolled
Gastrointestinal

Clinical Stage I Esophageal Adenocarcinoma AJCC v8

NCT01512589 2026-04-15

Proton Beam Therapy (PBT) Versus Intensity-Modulated Radiation Therapy (IMRT) Trial

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
147 enrolled
Gastrointestinal

Adenocarcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms

NCT03482791 2026-04-02

Proton Beam Therapy in the Treatment of Esophageal Cancer

Washington University School of Medicine

Phase NA Active not recruiting
22 enrolled 29 charts
Gastrointestinal

Esophageal Neoplasms

NCT02598349 2025-09-09

Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas

Proton Collaborative Group

Phase 2 Recruiting
60 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡